AG˹ٷ

STOCK TITAN

[Form 4] Regency Centers Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

C. Ronald Blankenship, a director of Regency Centers Corporation (REG), received 479 shares of common stock as payment of director fees under Regency's Omnibus Incentive Plan. The transaction is reported in Table I as a non-derivative acquisition (code A) and increases his direct beneficial ownership to 111,397 shares. The Form 4 indicates no derivative securities were acquired or disposed of and lists the reporting relationship as Director. The filing also shows the Form was submitted by one reporting person and executed by Michael R. Herman as attorney-in-fact.

This report documents a stock-based compensation event for a director and provides the post-transaction share total; no other classes of securities or material terms beyond the issuance for director fees are disclosed in the filing.

C. Ronald Blankenship, membro del consiglio di Regency Centers Corporation (REG), ha ricevuto 479 azioni ordinarie come compenso per la sua carica di amministratore ai sensi dell'Omnibus Incentive Plan di Regency. L'operazione è riportata nella Tabella I come acquisizione non derivata (codice A) e porta la sua partecipazione diretta a 111.397 azioni. Il Modulo 4 indica che non sono stati acquisiti o ceduti strumenti derivati e riporta la qualifica di Director. Il deposito segnala inoltre che il Modulo è stato presentato da un unico soggetto segnalante ed è stato sottoscritto da Michael R. Herman in qualità di procuratore.

Questa comunicazione documenta un evento di compenso in azioni per un consigliere e fornisce il totale delle azioni dopo la transazione; non sono rivelate altre classi di titoli né condizioni rilevanti oltre l'emissione a titolo di compenso per l'incarico di amministratore.

C. Ronald Blankenship, miembro del consejo de administración de Regency Centers Corporation (REG), recibió 479 acciones ordinarias como pago de honorarios por su función de director, según el Omnibus Incentive Plan de Regency. La operación se informa en la Tabla I como una adquisición no derivada (código A) y eleva su participación directa a 111.397 acciones. El Formulario 4 indica que no se adquirieron ni se dispusieron valores derivados y señala la relación informante como Director. La presentación también muestra que el Formulario fue enviado por una sola persona informante y firmado por Michael R. Herman como apoderado.

Este informe documenta un pago en acciones a un director y aporta el total de acciones tras la transacción; no se revelan otras clases de valores ni términos materiales más allá de la emisión por honorarios de director.

Regency Centers Corporation (REG)� 이사� C. Ronald Blankenship� Regency� Omnibus Incentive Plan� 따라 이사 보수� 보통� 479주를 수령했습니다. � 거래� � I� 비파� 취득(코드 A)으로 보고되었으며 그의 직접� 실소� 지분을 111,397�� 증가시킵니다. Form 4� 파생증권� 취득되거� 처분되지 않았음을 표시하고 보고 관계를 Director� 기재하고 있습니다. 제출서류에는 또한 해당 서식� � 명의 보고자에 의해 제출되었� Michael R. Herman� 대리인으로 서명했음� 명시되어 있습니다.

� 보고서는 이사� 대� 주식 보상 사건� 문서화하� 거래 � 주식 총액� 제공합니�; 이사 보수로의 발행 외에 다른 종류� 증권이나 중요� 조건은 공시되지 않았습니�.

C. Ronald Blankenship, administrateur de Regency Centers Corporation (REG), a reçu 479 actions ordinaires en règlement de ses jetons de présence au titre de l'Omnibus Incentive Plan de Regency. La transaction est déclarée dans le Tableau I comme une acquisition non dérivée (code A) et porte sa participation directe à 111 397 actions. Le formulaire 4 indique qu'aucun instrument dérivé n'a été acquis ni cédé et précise la relation déclarée comme Director. Le dépôt indique également que le formulaire a été soumis par une seule personne déclarant et signé par Michael R. Herman en qualité de mandataire.

Ce rapport documente un paiement en actions à un administrateur et fournit le total d'actions après la transaction ; aucune autre catégorie de titres ni condition matérielle au-delà de l'émission au titre des jetons de présence n'est divulguée dans le dépôt.

C. Ronald Blankenship, ein Direktor der Regency Centers Corporation (REG), erhielt 479 Stammaktien als Vergütung für seine Tätigkeit im Vorstand gemäß dem Omnibus Incentive Plan von Regency. Die Transaktion wird in Tabelle I als nicht-derivativer Erwerb (Code A) gemeldet und erhöht sein direktes wirtschaftliches Eigentum auf 111.397 Aktien. Das Formular 4 weist aus, dass keine derivativen Wertpapiere erworben oder veräußert wurden, und nennt die meldende Beziehung als Director. Die Einreichung zeigt außerdem, dass das Formular von einer meldenden Person eingereicht und von Michael R. Herman als Bevollmächtigter unterschrieben wurde.

Dieser Bericht dokumentiert eine aktienbasierte Vergütung für einen Direktor und gibt die Anzahl der Anteile nach der Transaktion an; keine weiteren Wertpapierklassen oder wesentlichen Bedingungen jenseits der Ausgabe als Vergütung für die Direktorentätigkeit werden in der Einreichung offengelegt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director C. Ronald Blankenship received 479 shares as director compensation, raising his direct holdings to 111,397 shares.

The Form 4 records a non-derivative acquisition (code A) of 479 common shares issued pursuant to the companys Omnibus Incentive Plan and reports the holders status as a director. The filing contains no derivative transactions, no disposals, and no additional compensation details such as per-share valuation. For investors, this is a routine equity issuance for director fees rather than a market purchase or a material change in ownership stake.

TL;DR: Transaction reflects director fee settlement in stock under the Omnibus Incentive Plan; filing is informational and routine.

The disclosure clearly states the shares were issued as director fees under the Omnibus Incentive Plan and shows the reporting relationship as Director. The Form 4 was filed by one reporting person and signed by an attorney-in-fact. There are no indications of transactions outside routine compensation; the report does not disclose any changes in control, derivative instruments, or unusual arrangements.

C. Ronald Blankenship, membro del consiglio di Regency Centers Corporation (REG), ha ricevuto 479 azioni ordinarie come compenso per la sua carica di amministratore ai sensi dell'Omnibus Incentive Plan di Regency. L'operazione è riportata nella Tabella I come acquisizione non derivata (codice A) e porta la sua partecipazione diretta a 111.397 azioni. Il Modulo 4 indica che non sono stati acquisiti o ceduti strumenti derivati e riporta la qualifica di Director. Il deposito segnala inoltre che il Modulo è stato presentato da un unico soggetto segnalante ed è stato sottoscritto da Michael R. Herman in qualità di procuratore.

Questa comunicazione documenta un evento di compenso in azioni per un consigliere e fornisce il totale delle azioni dopo la transazione; non sono rivelate altre classi di titoli né condizioni rilevanti oltre l'emissione a titolo di compenso per l'incarico di amministratore.

C. Ronald Blankenship, miembro del consejo de administración de Regency Centers Corporation (REG), recibió 479 acciones ordinarias como pago de honorarios por su función de director, según el Omnibus Incentive Plan de Regency. La operación se informa en la Tabla I como una adquisición no derivada (código A) y eleva su participación directa a 111.397 acciones. El Formulario 4 indica que no se adquirieron ni se dispusieron valores derivados y señala la relación informante como Director. La presentación también muestra que el Formulario fue enviado por una sola persona informante y firmado por Michael R. Herman como apoderado.

Este informe documenta un pago en acciones a un director y aporta el total de acciones tras la transacción; no se revelan otras clases de valores ni términos materiales más allá de la emisión por honorarios de director.

Regency Centers Corporation (REG)� 이사� C. Ronald Blankenship� Regency� Omnibus Incentive Plan� 따라 이사 보수� 보통� 479주를 수령했습니다. � 거래� � I� 비파� 취득(코드 A)으로 보고되었으며 그의 직접� 실소� 지분을 111,397�� 증가시킵니다. Form 4� 파생증권� 취득되거� 처분되지 않았음을 표시하고 보고 관계를 Director� 기재하고 있습니다. 제출서류에는 또한 해당 서식� � 명의 보고자에 의해 제출되었� Michael R. Herman� 대리인으로 서명했음� 명시되어 있습니다.

� 보고서는 이사� 대� 주식 보상 사건� 문서화하� 거래 � 주식 총액� 제공합니�; 이사 보수로의 발행 외에 다른 종류� 증권이나 중요� 조건은 공시되지 않았습니�.

C. Ronald Blankenship, administrateur de Regency Centers Corporation (REG), a reçu 479 actions ordinaires en règlement de ses jetons de présence au titre de l'Omnibus Incentive Plan de Regency. La transaction est déclarée dans le Tableau I comme une acquisition non dérivée (code A) et porte sa participation directe à 111 397 actions. Le formulaire 4 indique qu'aucun instrument dérivé n'a été acquis ni cédé et précise la relation déclarée comme Director. Le dépôt indique également que le formulaire a été soumis par une seule personne déclarant et signé par Michael R. Herman en qualité de mandataire.

Ce rapport documente un paiement en actions à un administrateur et fournit le total d'actions après la transaction ; aucune autre catégorie de titres ni condition matérielle au-delà de l'émission au titre des jetons de présence n'est divulguée dans le dépôt.

C. Ronald Blankenship, ein Direktor der Regency Centers Corporation (REG), erhielt 479 Stammaktien als Vergütung für seine Tätigkeit im Vorstand gemäß dem Omnibus Incentive Plan von Regency. Die Transaktion wird in Tabelle I als nicht-derivativer Erwerb (Code A) gemeldet und erhöht sein direktes wirtschaftliches Eigentum auf 111.397 Aktien. Das Formular 4 weist aus, dass keine derivativen Wertpapiere erworben oder veräußert wurden, und nennt die meldende Beziehung als Director. Die Einreichung zeigt außerdem, dass das Formular von einer meldenden Person eingereicht und von Michael R. Herman als Bevollmächtigter unterschrieben wurde.

Dieser Bericht dokumentiert eine aktienbasierte Vergütung für einen Direktor und gibt die Anzahl der Anteile nach der Transaktion an; keine weiteren Wertpapierklassen oder wesentlichen Bedingungen jenseits der Ausgabe als Vergütung für die Direktorentätigkeit werden in der Einreichung offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BLANKENSHIP C RONALD

(Last) (First) (Middle)
5004 GREEN TREE

(Street)
HOUSTON TX 77056

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REGENCY CENTERS CORP [ REG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 A 479 A (1) 111,397 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.
/s/ Michael R. Herman, Attorney-in-Fact for C. Ronald Blankenship 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did C. Ronald Blankenship report on Form 4 for Regency Centers (REG)?

The Form 4 reports the non-derivative acquisition of 479 shares of Regency Centers common stock as payment of director fees.

How many REG shares does C. Ronald Blankenship beneficially own after the reported transaction?

Following the reported transaction, he beneficially owns 111,397 shares directly.

Under what plan were the 479 REG shares issued?

The shares were issued pursuant to Regencys Omnibus Incentive Plan as director compensation, per the filings explanation of responses.

Was any derivative security reported in this Form 4 for REG?

No. Table II in the filing contains no entries; the reported transaction appears in Table I as a non-derivative security acquisition.

What is the reporting relationship of the person who filed the Form 4 for REG?

The filing lists the reporting person, C. Ronald Blankenship, as a Director of Regency Centers.
Regency Ctrs Corp

NASDAQ:REG

REG Rankings

REG Latest News

REG Latest SEC Filings

REG Stock Data

13.29B
180.23M
0.72%
104.4%
3.45%
REIT - Retail
AG˹ٷ Estate Investment Trusts
United States
JACKSONVILLE